Cita APA

Martini, M., de Pascalis, I., D’Alessandris, Q. G., Fiorentino, V., Pierconti, F., Marei, H. E., . . . Larocca, L. M. (2018). VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. BMC Cancer.

Chicago Style Citation

Martini, Maurizio, Ivana de Pascalis, Quintino Giorgio D’Alessandris, Vincenzo Fiorentino, Francesco Pierconti, Hany El-Sayed Marei, Lucia Ricci-Vitiani, Roberto Pallini, i Luigi Maria Larocca. "VEGF-121 Plasma Level As Biomarker for Response to Anti-angiogenetic Therapy in Recurrent Glioblastoma." BMC Cancer 2018.

Cita MLA

Martini, Maurizio, et al. "VEGF-121 Plasma Level As Biomarker for Response to Anti-angiogenetic Therapy in Recurrent Glioblastoma." BMC Cancer 2018.